Novartis Q4 Results slide image

Novartis Q4 Results

↓ ↑ Content Click below to navigate through the document Company overview Financial review Conclusions Appendix Innovation: Pipeline overview Financial performance Innovation: Clinical trials > Cardiovascular, Renal and Metabolic Immunology Neuroscience Oncology Other Global Health Abbreviations Cardiovascular, Renal and Metabolic References □ NOVARTIS Reimagining Medicine Novartis Q4 Results | January 31, 2024 46
View entire presentation